🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Evaluate the safety and tolerability of VX-659 in healthy subjects...
Status
Completed
Location
Multiple Locations
Start Date
2016-11
Trial ID
NCT03029455
Treatments Being Tested
RV568 is being developed as a possible treatment of smoking related lung di...
Status
Completed
Location
Multiple Locations
Start Date
2012-09
Trial ID
NCT01661244
This study is researching an experimental drug called ALN-APOC3 (called "st...
Status
Completed
Location
Arensia Exploratory Medicine at the Republican Clinical Hospital
Start Date
2025-01-27
Trial ID
NCT06784349
Treatments Being Tested
The purpose of this study is to investigate the safety and activity in the ...
Status
Completed
Location
Arensia Clinical Research Unit
Start Date
2019-08-14
Trial ID
NCT04073498
The purpose of this study is to evaluate the safety and efficacy of exogeno...
Status
Completed
Location
David Geffen School of Medicine at UCLA
Start Date
2018-12-05
Trial ID
NCT03769116
Treatments Being Tested
The purpose of this study is to assess the safety, tolerability and pharmac...
Status
Completed
Location
Quotient Sciences-Miami, Inc
Start Date
2023-06-27
Trial ID
NCT05950906
The purpose of this study is to evaluate safety, tolerability, immunogenici...
Status
Completed
Location
CMAX Clinical Research
Start Date
2020-12-30
Trial ID
NCT05490017
This is a First in Human (FIH), double-blinded, parallel-group, randomised,...
Status
Completed
Location
CTC Clinical Trial Consultants AB
Start Date
2019-07-03
Trial ID
NCT04036227
This will be a FTIH study which aims to evaluate safety, tolerability, phar...
Status
Terminated
Location
GSK Investigational Site
Start Date
2021-09-20
Trial ID
NCT05044325
Treatments Being Tested
This is a Phase I Randomised Single-blind Placebo-controlled Study to Asses...
Status
Completed
Location
Research Site
Start Date
2023-05-02
Trial ID
NCT05848440